Syncom Formulations (India) Limited has announced the closure of its trading window for dealing in the company's shares. This closure will be effective from January 1, 2026, and will remain in effect until 48 hours after the declaration of the Unaudited Standalone & Consolidated Financial Results for the quarter and Nine Months ended December 31, 2025. The decision is in compliance with SEBI (Prohibition of Insider Trading) Regulation, 2015, and relevant BSE circulars. All promoters, directors, key managerial personnel (KMPs), designated employees, connected persons, fiduciaries, and their immediate relatives are advised not to trade in the company's shares during this period. Their PAN details will be frozen by the designated depository, CDSL, to enforce this restriction. The company will inform the date of the Board of Directors' meeting to approve these financial results in due course. Syncom Formulations is also in the process of filing the necessary disclosure in XBRL format and will host it on the company's website.